Clinical Trial Protocol for ROSELLA: a phase 3 study of relacorilant in combination with nab-paclitaxel versus nab-paclitaxel monotherapy in advanced platinum-resistant ovarian cancer.

Published in:

Journal of Gynecologic Oncology, 2024, v. 35, n. 4, p. 1, doi. 10.3802/jgo.2024.35.e111

By:

• Olawaiye, Alexander B.;
• Jae-Weon Kim;
• Bagameri, Andrea;
• Bishop, Erin;
• Chudecka-Głaz, Anita;
• Devaux, Alix;
• Gladieff, Laurence;
• Gordinier, Mary E.;
• Korach, Jacob;
• McCollum, Michael E.;
• Mileshkin, Linda;
• Monk, Bradley J.;
• Nicum, Shibani;
• Nogueira-Rodrigues, Angélica;
• Oaknin, Ana;
• O'Malley, David M.;
• Orlando, Mauro;
• Dreiling, Lyndah;
• Tudor, Iulia C.;
• Lorusso, Domenica

Publication type:

Article